-
WHAT'S NEW
Position Open: Director, Institute of Molecular and Genomic Medicine, National Health Research Institutes, Taiwan Position Open: Director, Institute of Biotechnology and Pharmaceutical Research, National Health Research Institutes, Tai 2020 Biomedical Research Symposium of NHRI canceled due to COVID-19 outbreakMORE -
PRESS RELEASE
US FDA approves Taiwan-developed anti-cancer drug-delivery system for phase I clinical study NHRI scientists harness nanoparticles to improve use of weight loss drug s by reduc ing their side effects National Health Research Institutes and Millennium Pharmaceuticals, Inc., a wholly-owned subsidiary of Takeda PharmaceutiMORE
Four Indicators
-
Talent Education
Our hospital is committed to cultivating medical personnel to apply their knowledge to promote the health of citizens
-
Research And Develop
Our hospital specializes in medical science and technology research to keep the country's medicine constantly improving
-
Academic Cooperation
In order to strengthen the academic cooperation relationship of the medical and health circles in our country
-
Technology Transfer
In order to promote the application of medical technology, the quality of medicine is continuously improved
Service Resources
+- Value-Added MedChem Innovation Center
- Biotechnology Pharmacy Core Facility Service Platform
- A nationwide survey on the prevalence of dementia and disability in communities
- IBEN Service
- The Taiwan Mechanical Ventilation Performance Database System
- Taiwan Zebrafish Core Facility
- National Health Research Institutes Biobank
- Core Instrument Center
- Technology Transfer and Incubation Center
- Child Health Research Center
- Fostering Addiction Treatment and Intervention Professionals
- Bioinformatics Core Facility for NHRI
Results Statistics
+Web Links
